ID: ALA5276726

Max Phase: Preclinical

Molecular Formula: C20H33NO2

Molecular Weight: 319.49

Associated Items:

Representations

Canonical SMILES:  CCCCCNC(=O)c1cc(C(C)(C)C)cc(C(C)(C)C)c1O

Standard InChI:  InChI=1S/C20H33NO2/c1-8-9-10-11-21-18(23)15-12-14(19(2,3)4)13-16(17(15)22)20(5,6)7/h12-13,22H,8-11H2,1-7H3,(H,21,23)

Standard InChI Key:  JLKHAOFAPVVKHI-UHFFFAOYSA-N

Associated Targets(Human)

Orphan nuclear receptor LRH-1 736 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 319.49Molecular Weight (Monoisotopic): 319.2511AlogP: 4.91#Rotatable Bonds: 5
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.08CX Basic pKa: CX LogP: 6.25CX LogD: 6.24
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.76Np Likeness Score: -0.48

References

1. Lang A, Isigkeit L, Schubert-Zsilavecz M, Merk D..  (2021)  The Medicinal Chemistry and Therapeutic Potential of LRH-1 Modulators.,  64  (23.0): [PMID:34839661] [10.1021/acs.jmedchem.1c01663]

Source